Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
LYNX1 encodes a member of the Ly-6/neurotoxin gene family, a group of lymphocyte antigens that attach to the cell surface by a glycosylphosphatidylinositol anchor and have a unique structure showing conserved 8-10 cysteine residues with a characterist. Additionally we are shipping Ly6/neurotoxin 1 Proteins (7) and many more products for this protein.
Showing 3 out of 3 products:
results show that some functional and behavioral aspects of alpha6-nAChRs are modulated by lynx1
These findings provide new insights into the acetylcholine receptor (show CHRNA1 Antibodies)-mediated regulatory mechanism of SLURP-2 expression in keratinocytes.
These studies suggest that lynx1 is a potential target both for development of drugs that may limit lung cancer growth as well as for drugs that may be effective for asthma or COPD (show ARCN1 Antibodies) treatment.
This epigenome-wide DNA methylation (show HELLS Antibodies) analysis in postmortem hippocampus and prefrontal cortex specimens confirmed LYNX1 DNA methylation (show HELLS Antibodies) profiles in major depression.
Micromolar affinities and fast washout rates measured for ws-LYNX1 and its mutants are in contrast to nanomolar affinities and irreversibility of binding for alpha-bungarotoxin and similar snake alpha-neurotoxins also targeting alpha7 nAChR (show CHRNA7 Antibodies).
Computer modeling, based on ws-LYNX1 NMR structure and AChBP x-ray structure, revealed a possible mode of ws-LYNX1 binding.
LY-6K (show Ly6k Antibodies),a novel member protein of the Ly-6/uPAR (show PLAUR Antibodies) superfamily, is a significant new molecular marker for diagnosis and gene therapy in patients with breast cancer.
decreased Lynx1 is associated with squamous cell lung carcinoma
LY-6K (show Ly6k Antibodies) meaningfully participates in breast cancer cell metastasis
The results of this study suggested greater spine loss as a better correlate of elevated functional plasticity in adult Lynx1-KO mice.
tPA (show PLAT Antibodies) activity in V1 can be unmasked following 4 d of monocular deprivation when mice older than 2 months are raised in standard cages by the genetic removal of Lynx1, a negative regulator of adult plasticity.
lynx1 KO animals over 1 year of age have clear ultrastructural differences in the striatum.
Lynx1 has a role in shifting alpha4beta2 nicotinic receptor subunit stoichiometry by affecting assembly in the endoplasmic reticulum
study identified an increase in expression of Lynx1 protein that prevented plasticity in the primary visual cortex late in life; Lynx1 expression maintains stability of mature cortical networks in the presence of cholinergic innervation
Results show that lynx1 colocalizes with nAChRs on CNS neurons and physically associates with nAChRs and enhances receptor desensitization, resulting in a novel type of functional modulation
Lynx1 appears to act as a negative modulator of alpha7 nAChR (show CHRNA7 Antibodies)-induced events by inhibiting Src (show SRC Antibodies) activation.
This gene encodes a member of the Ly-6/neurotoxin gene family, a group of lymphocyte antigens that attach to the cell surface by a glycosylphosphatidylinositol anchor and have a unique structure showing conserved 8-10 cysteine residues with a characteristic spacing pattern. Functional analysis indicates that this protein is not a ligand or neurotransmitter but has the capacity to enhance nicotinic acetylcholine receptor function in the presence of acetylcholine. This gene may also play a role in the pathogenesis of psoriasis vulgaris. Alternatively spliced variants encoding different isoforms have been identified.
Ly-6 neurotoxin-like protein 1
, ly-6/neurotoxin-like protein 1
, secreted Ly-6/uPAR domain-containing protein 2
, secreted Ly-6/uPAR-related protein 2
, secreted Ly6/uPAR related protein 2
, secreted Ly6/uPAR related protein-2